193 related articles for article (PubMed ID: 7618437)
1. Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.
Kumamoto T; Ueyama H; Watanabe S; Yoshioka K; Miike T; Goll DE; Ando M; Tsuda T
Acta Neuropathol; 1995; 89(5):399-403. PubMed ID: 7618437
[TBL] [Abstract][Full Text] [Related]
2. Proteasome expression in the skeletal muscles of patients with muscular dystrophy.
Kumamoto T; Fujimoto S; Ito T; Horinouchi H; Ueyama H; Tsuda T
Acta Neuropathol; 2000 Dec; 100(6):595-602. PubMed ID: 11078210
[TBL] [Abstract][Full Text] [Related]
3. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
Richard I; Roudaut C; Marchand S; Baghdiguian S; Herasse M; Stockholm D; Ono Y; Suel L; Bourg N; Sorimachi H; Lefranc G; Fardeau M; Sébille A; Beckmann JS
J Cell Biol; 2000 Dec; 151(7):1583-90. PubMed ID: 11134085
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles.
Ashida Y; Himori K; Tokuda N; Naito A; Yamauchi N; Takenaka-Ninagawa N; Aoki Y; Sakurai H; Yamada T
Am J Physiol Cell Physiol; 2022 Sep; 323(3):C885-C895. PubMed ID: 35912995
[TBL] [Abstract][Full Text] [Related]
5. Calpastatin (the endogenous calpain inhibitor) and membrane protein degradation in cell fusion.
Kosower NS; Barnoy S
Methods Mol Biol; 2000; 144():181-94. PubMed ID: 10818763
[No Abstract] [Full Text] [Related]
6. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
7. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3.
Wei W; Fareed MU; Evenson A; Menconi MJ; Yang H; Petkova V; Hasselgren PO
Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R580-90. PubMed ID: 15563579
[TBL] [Abstract][Full Text] [Related]
8. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
Barnoy S; Glasner T; Kosower NS
Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
[TBL] [Abstract][Full Text] [Related]
9. Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in postmortem muscle.
Doumit ME; Koohmaraie M
J Anim Sci; 1999 Jun; 77(6):1467-73. PubMed ID: 10375223
[TBL] [Abstract][Full Text] [Related]
10. Changes in the calpains and calpastatin during postmortem storage of bovine muscle.
Boehm ML; Kendall TL; Thompson VF; Goll DE
J Anim Sci; 1998 Sep; 76(9):2415-34. PubMed ID: 9781498
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
12. The calpain-calpastatin system and protein degradation in fusing myoblasts.
Barnoy S; Glaser T; Kosower NS
Biochim Biophys Acta; 1998 Mar; 1402(1):52-60. PubMed ID: 9551085
[TBL] [Abstract][Full Text] [Related]
13. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
14. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.
Badalamente MA; Stracher A
Muscle Nerve; 2000 Jan; 23(1):106-11. PubMed ID: 10590413
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
16. Association of calpain (Ca(2+)-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts.
Barnoy S; Zipser Y; Glaser T; Grimberg Y; Kosower NS
J Cell Biochem; 1999 Sep; 74(4):522-31. PubMed ID: 10440922
[TBL] [Abstract][Full Text] [Related]
17. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.
Keira Y; Noguchi S; Minami N; Hayashi YK; Nishino I
J Biochem; 2003 May; 133(5):659-64. PubMed ID: 12801918
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology.
Spencer MJ; Mellgren RL
Hum Mol Genet; 2002 Oct; 11(21):2645-55. PubMed ID: 12354790
[TBL] [Abstract][Full Text] [Related]
19. Calpains and muscular dystrophies.
Tidball JG; Spencer MJ
Int J Biochem Cell Biol; 2000 Jan; 32(1):1-5. PubMed ID: 10661889
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin.
Grozdanovic Z; Gosztonyi G; Gossrau R
Acta Histochem; 1996 Jan; 98(1):61-9. PubMed ID: 9054190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
